CompaniesCOAG

Ask About This Stock Analyze with Claude Go to Earnings

Hemab Therapeutics Holdings Inc

COAGBiotechnology

Add to Watchlist Set Price Alert Add to Portfolio

Go to Earnings Ask About This Stock

$38.77

− 9.44%− 4.04

After HoursPrevious Close $42.81

Alpaca · SIPUpdated 16:00 NY15 Minutes Delayed

52-Week Range49% Into the Band

Low: $23.00; 69% Above the Low
High: $55.42; 30% Below the High

Company Profile

FinnhubUpdated 01:05 NY

Market Cap: $1.81 B; At the Live Price; 0.00% of the Tracked Total
Market Cap Rank: 808.; Of 1,535 Tracked Companies

COAGLargest: AAPL · $5.09 T807. TY · $8.54 M Ahead809. WKC · $3.31 M Behind

Country: United States
Exchange: Nasdaq
IPO Date: May 1, 2026

52-Week Range49% Into the Band

Low: $23.00; 69% Above the Low
High: $55.42; 30% Below the High

Company Profile

Company Analysis

Tool: Claude

Claude reads this company in two focuses: technical (1⁠–⁠2 weeks) and stock picking (3⁠–⁠6 months). While the market is open it takes the live price.

Analyse This Company

Company Summary

Next Earnings: Tuesday, November 10; Before Open

Ask About This Stock

Ask what you want to know about this stock; Claude answers only from the data on this page and gives no buy or sell advice. Sign in to ask.

Data an Answer Can Draw OnLast SessionValuationAnalyst RatingsEarnings HistoryHeadlines

Answers are written with Claude only from this page's data and the last completed session's close; every number in an answer must appear in that data. Not investment advice.

Why It Moved This Week

Last 5 Sessions · November 4-10

Over Five Sessions

− 10.05%

S&P 500 − 0.59%9.46 Points Below the Market

Wed+ 4.6%
Thu+ 1.1%
Fri+ 7.6%
Mon− 12.7%Volume 2.5×
Tue− 9.4%Volume 1.9×

Claude is preparing the note…

Valuation

Buy Side 92% · 12 Analysts

Key Metrics

Rule Check

P/E Ratio: –
P/B: 3.99
Earnings per Share: –
Dividend Yield: –
Beta: -1.53
Debt / Equity: 0.00
Volume: 817,157

Analyst Ratings

92%Lean Buy

Strong Buy: 4; 33%
Buy: 7; 58%

Moving Averages

Latest Price: $38.77
50-Day: $37.32+ 3.89%
100-Day: $40.69− 4.71%
200-Day: –

Average close over the last 50, 100 and 200 trading days. Above the average, buyers led that stretch; below it, sellers did. The percentage next to it is the gap.

Sharia Screening

Needs Review

We don't have this company's sub-industry, so the line-of-business criterion wasn't screened.

Interest-Bearing Debt / Market Cap: 0.0%; 0Limit 33%
Cash and Interest-Bearing Assets / Market Cap: 25.3%; 0Limit 33%

This Is Not a Religious Ruling

It is an automated pre-screen based on the line of business and AAOIFI's widely used financial thresholds; a final judgement rests with your own school of thought and the certification boards that audit the filings.

The interest-income test (5% of revenue) needs a revenue breakdown our free data source doesn't provide, so that criterion isn't screened.

Analyst Distribution Change

The buy-side share rose 1 points in 3 months: 91% → 92%.

Buy-Side ShareStrong Buy 4Buy 7Hold 1Sell 0Strong Sell 0

Table With Numbers

Analyst Ratings	Aug 26	Sep 26	Oct 26	Nov 26	Change
Strong Buy	4	4	4	4	0
Buy	6	6	6	7	+1
Hold	1	1	1	1	0
Sell	0	0	0	0	0
Strong Sell

How to Read

Net change in the monthly distribution: a rise in a bucket can come from an analyst changing their rating or a new one joining. Individual rating changes and price targets are not in the source.

FinnhubUpdated 01:05 NY

Technical Snapshot

Nov 10, 2026 Close

20-Day Average: $38.18+ 1.55%
RSI (14): 49.6
MACD: +2.30
Signal: +1.70
Histogram: +0.60Crossed 21 Sessions Ago
Daily Range (ATR 14): $3.44Share of Price 8.9%
Volume · Last Session: 817,157Versus Average 1.66x
Volume · 20-Day Average: 493,390

Pivot Levels

Support 2: 32.25
Support 1: 35.51
Pivot: 39.83
Resistance 1: 43.09
Resistance 2: 47.41

How to Read

Indicators are computed from the last completed session's close and carry no opinion; the same calculation feeds the stocks on the Technical Analysis page. The 50, 100 and 200-day averages are in the Valuation section.

Alpaca · SIPUpdated 17:56 NY15 Minutes Delayed

Company Analysis

Tool: Claude

Technical FocusNo report for this focus yet.
Analyse with Claude
Stock Selection FocusNo report for this focus yet.
Analyse with Claude

Claude writes a second opinion independent of the site's own analysis; while the market is open it reads the live price.

Earnings

Next Report Tuesday, November 10 · Before Open

Earnings Preview

Claude is preparing the note…

Next Earnings

Tuesday, November 10

Before Open

Add to Calendar Earnings Page

EPS Estimate: − $0.53
Revenue Estimate: $0.00

Beat Record

No beats in the last 2 quarters

Expected Move

Tuesday, November 10 · Before Open

Priced by Options: Option quotes for this expiry could not be loaded.
Average Absolute Move: No past report dates are on record for this company yet.

How It's Calculated

The at-the-money call and put mid prices added together, divided by the share price. It prices the whole move until expiry, not only the earnings. Quotes come from the derived indicative feed, not OPRA itself.

Alpaca · SIPUpdated 14:26 NY15 Minutes Delayed

Past Earnings

ForecastActual

Q2 '26
Q3 '26

Period	Report Date	Surprise	EPS · Forecast	EPS · Actual	Revenue · Actual

Dividends

No cash dividends in the past three years.

US dividends are taxed at source: under the US–Türkiye treaty, individual investors pay 20% with a W-8BEN form on file and 30% without. Amounts are gross, per share, before tax. What Is W-8BEN Tax Guide

Alpaca Corporate ActionsUpdated 14:26 NY

In Context

Insider Transactions

Last 90 Days

No open-market buys or sales in the last 90 days; the moves listed come from grants, tax withholding, gifts or option exercises.

Monthly Share Purchase Ratio (MSPR)

Latest (Sep 26): +100

Dec 25Nov 26

Insider	Date	Transaction	Shares	Price	Value
Keli WalbertDirector	Sep 24	GrantDerivative	+36,000	–	–

Show AllLess

How to Read

Colored chips are open-market decisions; dimmed rows are grants, tax withholding, gifts or option exercises, which are not trading decisions.

Rows come from SEC Form 4 filings; parts of the same filing are merged into one transaction. The summary counts only open-market buys and sales: grants, tax withholding, gifts and option exercises are not trading decisions. Pre-planned (10b5-1) sales are not flagged separately by the source.

The role under each name is taken from the person's latest Form 4 filing; when the filing cannot be read, the row shows the name only.

MSPR runs from −100 to 100: 100 means only buying that month, −100 only selling. An empty month means the source has no computed value for it; recent months can reach the source late.

FinnhubUpdated 14:26 NY

Company News

Show All

To Understand This

Earnings Reports: What to Read, HowThe book opens once a quarter — and the market really only reads three lines.P/E and the Valuation RatiosYou can't tell whether a stock is cheap or expensive by looking at its price.Market Cap, Float and SplitsA company's real size is not the share price — it's the price times the share count.

Q3 2026Sep 2026Nov 10, 2026Revenue $0.00	Nov 10, 2026	− $0.05	− $0.53	− $0.58Forecast − $0.53	$0.00Forecast $0.00
Q2 2026	No Data	− $0.04	− $0.76	− $0.80Forecast − $0.76	No Data

Overview

Company Profile

Company Profile

Company Analysis

Company Summary

Ask About This Stock

Why It Moved This Week

Valuation

Key Metrics

Analyst Ratings

Moving Averages

Sharia Screening

Analyst Distribution Change

Technical Snapshot

Company Analysis

Earnings

Earnings Preview

Next Earnings

Expected Move

Past Earnings

Dividends

In Context

Insider Transactions

Company News

Company Analysis

Company Summary

Ask About This Stock

Why It Moved This Week

Sharia Screening

Technical Snapshot

Company Analysis

Next Earnings

Expected Move

Dividends

Insider Transactions

Company Profile

Analyst Ratings

Analyst Distribution Change

Earnings Preview